These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22403289)

  • 1. Co-author of Wakefield paper on MMR vaccine wins his appeal against decision by GMC to strike him off.
    Dyer C
    BMJ; 2012 Mar; 344():e1745. PubMed ID: 22403289
    [No Abstract]   [Full Text] [Related]  

  • 2. Wakefield was dishonest and irresponsible over MMR research, says GMC.
    Dyer C
    BMJ; 2010 Jan; 340():c593. PubMed ID: 20118180
    [No Abstract]   [Full Text] [Related]  

  • 3. Wakefield is struck off for the "serious and wide-ranging findings against him".
    Kmietowicz Z
    BMJ; 2010 May; 340():c2803. PubMed ID: 20498165
    [No Abstract]   [Full Text] [Related]  

  • 4. GMC case against Wakefield's colleague was "superficial," says appeal.
    Dyer C
    BMJ; 2012 Feb; 344():e1103. PubMed ID: 22334554
    [No Abstract]   [Full Text] [Related]  

  • 5. Andrew Wakefield drops libel case against Channel 4.
    Dyer C
    BMJ; 2007 Jan; 334(7584):60. PubMed ID: 17218681
    [No Abstract]   [Full Text] [Related]  

  • 6. Wakefield sues BMJ over MMR articles.
    Dyer C
    BMJ; 2012 Jan; 344():e310. PubMed ID: 22235022
    [No Abstract]   [Full Text] [Related]  

  • 7. Appeal court reinstates GMC penalties on two doctors.
    Dyer C
    BMJ; 2007 Jan; 334(7586):177. PubMed ID: 17255595
    [No Abstract]   [Full Text] [Related]  

  • 8. Paediatrician David Southall wins appeal against GMC.
    Dyer C
    BMJ; 2010 Apr; 340():c2195. PubMed ID: 20406880
    [No Abstract]   [Full Text] [Related]  

  • 9. Texas judge throws out Wakefield's libel action against BMJ.
    Dyer C
    BMJ; 2012 Aug; 345():e5328. PubMed ID: 22867918
    [No Abstract]   [Full Text] [Related]  

  • 10. GMC hearing against Wakefield and colleagues opens.
    Dyer O
    BMJ; 2007 Jul; 335(7610):62-3. PubMed ID: 17626928
    [No Abstract]   [Full Text] [Related]  

  • 11. Referral of Dr. Peter Mansfield to the GMC. Health authority made right decision.
    Alexander M
    BMJ; 2001 Dec; 323(7324):1304. PubMed ID: 11764750
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. College investigates whether Wakefield was guilty of scientific fraud.
    Hawkes N
    BMJ; 2011 Mar; 342():d2010. PubMed ID: 21447591
    [No Abstract]   [Full Text] [Related]  

  • 14. GMC decision in Southall case challenged in High Court.
    Dyer C
    BMJ; 2005 Mar; 330(7491):556. PubMed ID: 15760979
    [No Abstract]   [Full Text] [Related]  

  • 15. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the safety and immunogenicity of lyophilized live attenuated measles-mumps-rubella combined vaccine].
    Liu G; Fang H; Feng Z; Guo W; Dong C; Zhang W; Ze W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Dec; 23(6):435-7. PubMed ID: 12667354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMR scare: UCL's response.
    Tooke J; Price D
    BMJ; 2011 Jan; 342():d460. PubMed ID: 21266429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.